FBRX, Forte Biosciences, Inc

"Loading Stock Price & Valuation Data ..."

Agentic AI (Pro) Picks for FBRX

Subscribe to iPick.ai (Pro) to use Power Picks, Hidden-Gem Picks, and more.


News Summary: Subscribe

Unlock News Summary by Subscribing to iPick.ai Premium!





Unlock Ask FBRX by Subscribing to iPick.ai Premium!



Stock Chart




Latest YouTube Video:



CEO:Dr. Paul A. Wagner Ph.D.

Headquarter: 3060 Pegasus Park Drive, Building 6, Dallas, TX, United States, 75247

Industry: Biotechnology,   Investment Track: -,   Employees: -

Business Summary

Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company's lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as graft-vs-host disease, vitiligo, and alopecia areata, as well as for celiac disease and non-segmental vitiligo. Forte Biosciences, Inc. is headquartered in Dallas, Texas.